EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyaluronic Acid Hybrid Cooperative Complexes Nearing 10 Years of Use: Update on Safety Assessment Based on Post‐Marketing Surveillance Data

Giovanni Salti, Antonello Tateo, Daniel Cassuto, Francesca Arrigoni, Chiara Godina, Federica Mazzola, Clara Cigni iD, Franco Grimolizzi, Gilberto Bellia

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Giovanni Salti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medlight Institute, Florence, Italy. Hauptthemen laut MEDLINE: Hyaluronic Acid, Dermal Fillers, Cosmetic Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hybrid cooperative complex hyaluronic acid (HCC HA) is a novel, widely used injectable developed using the patented NAHYCO Hybrid Technology for the treatment of the face and body, respectively.

Aim

To examine the safety profile of HCC HA from global post‐marketing surveillance data.

Methods

Post‐marketing adverse events (AEs) reported for HCC HA injected to the face (Profhilo, HCC‐HA PROF , IBSA Farmaceutici Italia Srl, Italy) from January 1, 2018 to October 31, 2023 and to the body (Profhilo Body, HCC‐HA PROF‐B , IBSA Farmaceutici Italia Srl, Italy) from January 1, 2020 to October 31, 2023 were analyzed. Patient exposure and the proportion of exposed patients with a safety complaint were also estimated.

Results

The total number of patients exposed to HCC‐HA PROF and HCC‐HA PROF‐B globally was projected to be 1 091 956 and 27 692, respectively. There was a total of 371 AEs recorded for HCC‐HA PROF , and 11 AEs reported for HCC‐HA PROF‐B , corresponding to 0.034% and 0.040% of the patients, respectively. The most common AEs were edema, erythema, and discomfort, which are consistent with the manner and location of administration, and the AEs are frequently reported following treatment. The proportion of exposed patients with a safety complaint was low, with 0.026%–0.050% and 0%–0.013% of patients exposed to HCC‐HA PROF or HCC‐HA PROF‐B experiencing a safety complaint, respectively.

Conclusions

Post‐marketing surveillance indicated favorable safety profiles for HCC‐HA PROF and HCC‐HA PROF‐ , with the most common AEs expected and/or related to the method or site of administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidDermal FillersCosmetic TechniquesHumansProduct Surveillance, PostmarketingFemaleMiddle AgedAdultMaleAgedSkin AgingEdema

Stichwörter der Autor:innen

hyaluronic acidhybrid cooperative complexesinjectable complicationspost‐marketing safety

Substanzen

Hyaluronic AcidDermal Fillers

Autor:innen und Institutionen

  • Medlight Institute, Florence, Italy.
  • Private Practice, Milan and Pavia, Italy.
  • Private Practice, Israel.
  • Private Practice, Milan, Italy.
  • Agorà Clinical Educational Centre, Milan, Italy.
  • IBSA Institut Biochimique SA, Lugano, Switzerland.

ORCID-Profile: Clara Cigni

Zitieren

APA

Salti, G., Tateo, A., Cassuto, D., Arrigoni, F., Godina, C., Mazzola, F., Cigni, C., Grimolizzi, F., & Bellia, G. (2025). Hyaluronic Acid Hybrid Cooperative Complexes Nearing 10 Years of Use: Update on Safety Assessment Based on Post‐Marketing Surveillance Data. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70197

Vancouver

Salti G, Tateo A, Cassuto D, Arrigoni F, Godina C, Mazzola F, et al. Hyaluronic Acid Hybrid Cooperative Complexes Nearing 10 Years of Use: Update on Safety Assessment Based on Post‐Marketing Surveillance Data. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70197

BibTeX
@article{Salti2025,
  author = {Salti, Giovanni and Tateo, Antonello and Cassuto, Daniel and Arrigoni, Francesca and Godina, Chiara and Mazzola, Federica and Cigni, Clara and Grimolizzi, Franco and Bellia, Gilberto},
  title = {Hyaluronic Acid Hybrid Cooperative Complexes Nearing 10 Years of Use: Update on Safety Assessment Based on Post‐Marketing Surveillance Data},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70197}
}
Kostenlos starten →